We are partnered with a next generation biotechnology company based in San Diego that is leveraging its proprietary chemical proteomics platform.
A successful candidate will be expected to use his/her toxicology expertise to guide safety assessment, design and interpret in vitro/in vivo studies to evaluate the safety profiles of our covalently and non-covalently targeted small molecules according to regulatory guidelines. You will work closely with the toxicology function, CROs, and multidisciplinary drug discovery/development teams to progress promising therapeutics to the clinic.
- PhD. in pharmacology, toxicology, or closely related biomedical disciplines
- Diplomate of American Board of Toxicology is highly desired
- 10+ years of post-graduate experiences which include minimally 6-7 years of experiences in a pharmaceutical or biotechnology industry setting